The global veterinary medical devices market is projected to grow from $6.5 billion in 2024 to $9.1 billion by 2030, representing a 6.1% compound annual growth rate (CAGR) during 2025–2030, according to BCC Research's report Global Veterinary Medical Devices Market. Pet humanization, expanding insurance coverage, rising companion animal populations, premium veterinary care and rapid device innovation are identified as key growth drivers. North America holds the largest regional share at 55.9%; U.S. gross written pet-insurance premiums reached $4.7 billion in 2024 across 6.4 million insured pets. AI-powered diagnostic imaging, point-of-care (PoC) in vitro diagnostics that can produce results within 15 minutes, and cloud-connected software-as-a-service (SaaS) platforms linked to Practice Management Systems are supporting clinic upgrades and new revenue opportunities. Asia-Pacific, Latin America and the Middle East offer long-term growth potential as incomes, economic development and livestock production rise, although these markets remain underpenetrated. Emerging products include AI-enabled hematology analyzers, wireless handheld PoC ultrasound, wearable monitoring devices, 3D-printed orthopedic implants and prosthetics, platelet-rich plasma and stem cell therapy, cold plasma therapy devices, and augmented MRI solutions. The competitive landscape includes IDEXX Laboratories Inc., Zoetis Services LLC, Antech Diagnostics Inc., Shenzhen Mindray Animal Medical Technology Co. Ltd., B. Braun Vet Care GmbH (B. Braun SE), Medtronic, ICU Medical Inc., Midmark Corp., Covetrus and Bionet Co. Ltd. BCC Research characterizes the sector as a structurally resilient growth category with defensive characteristics, while noting that clinic capital constraints and regulatory complexity may slow technology adoption and lengthen replacement cycles.